[1]莫俊贤,冼 磊.miRNA-21及PTEN在肺腺癌组织中的表达及意义[J].医学信息,2020,33(09):77-79.[doi:10.3969/j.issn.1006-1959.2020.09.022]
　MO Jun-xian,XIAN Lei.Expression and Significance of miRNA-21 and PTEN in Lung Adenocarcinoma[J].Medical Information,2020,33(09):77-79.[doi:10.3969/j.issn.1006-1959.2020.09.022]
点击复制

miRNA-21及PTEN在肺腺癌组织中的表达及意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年09期
页码:
77-79
栏目:
论著
出版日期:
2020-05-01

文章信息/Info

Title:
Expression and Significance of miRNA-21 and PTEN in Lung Adenocarcinoma
文章编号:
1006-1959（2020）09-0077-03
作者:
莫俊贤; 冼 磊
（1.广西医科大学第七附属医院胸心外科，广西 梧州 543000；2.广西医科大学第二附属医院胸心外科，广西 南宁 530007）
Author(s):
MO Jun-xian; XIAN Lei
(1.Department of Thoracic and Cardiovascular Surgery,the Seventh Affiliated Hospital of Guangxi Medical University,Wuzhou 543000,Guangxi,China;2.Department of Thoracic and Cardiovascular Surgery,the Second Affiliated Hospital of Guangxi Medical University,Nanning 530007,Guangxi,China)
关键词:
肺腺癌; miRNA-21; PTEN; 实时荧光定量PCR
Keywords:
Lung adenocarcinoma; miRNA-21; PTEN; Real-time fluorescence quantitative PCR
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2020.09.022
文献标志码:
A
摘要:
目的 观察肺腺癌组织中miRNA-21的表达情况，为miRNA-21成为新的肺腺癌靶点基因提供临床依据。方法 收集自2017年6月~2019年6月广西医科大学第二附属医院共53例肺腺癌患者的癌组织、配对癌旁组织以及12例非癌疾病肺组织。采用实时荧光定量PCR法（qPCR）检测其miRNA-21和PTEN的表达情况，并分析二者的相关性。结果 肺腺癌组织中miRNA-21表达高于癌旁组织和非癌肺组织，其中Ⅲ~Ⅳ期患者中高于Ⅰ~Ⅱ期患者；肺腺癌组织中PTEN低于癌旁组织和非癌肺组织，其中Ⅲ~Ⅳ期患者中低于Ⅰ~Ⅱ期患者，差异有统计学意义（P＜0.05）； miRNA-21和PTEN的表达呈负相关（r=-0.663，P＜0.05）。结论 miRNA-21在肺腺癌组织中抑制了PTEN的表达，miRNA-21极有可能成为肺腺癌的治疗靶点。
Abstract:
Objective To observe the expression of miRNA-21 in lung adenocarcinoma tissues and provide a clinical basis for miRNA-21 to become a new target gene for lung adenocarcinoma.Methods From June 2017 to June 2019, 53 cases of lung adenocarcinoma patients’ cancer tissues, paired paracancerous tissues and 12 cases of non-cancer disease lung tissues were collected from the Second Affiliated Hospital of Guangxi Medical University. Real-time fluorescence quantitative PCR (qPCR) was used to detect the expression of miRNA-21 and PTEN, and to analyze the correlation between the two.Results The expression of miRNA-21 in lung adenocarcinoma tissues was higher than that in paracancerous tissues and non-cancerous lung tissues. Among them, stage III to IV patients were higher than those in stage I to II patients; PTEN in lung adenocarcinoma tissues was lower than that in paracancerous tissues and noncancerous lung tissues.Among them, the patients in stage III to IV were lower than those in stage I to II, the difference was statistically significant (P<0.05); the expression of miRNA-21 and PTEN was negatively correlated(r=-0.663,P<0.05).Conclusion miRNA-21 inhibits the expression of PTEN in lung adenocarcinoma tissues. miRNA-21 is very likely to be a therapeutic target for lung adenocarcinoma.

参考文献/References:

[1]Siegel RL,Miller KD,Jemal A.Cancer statistics,2016[J].CA Cancer J Clin,2016,66(1):7-30.[2]Hosseinahli N,Aghapour M,Duijf PHG,et al.Treating cancer with microRNA replacement therapy:A literature review[J].Journal of Cellular Physiology,2018,233(8):5574-5588.[3]Hu M,Zhu S,Xiong S,et al.MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review)[J].Oncol Rep, 2019,41(3):1439-1454. [4]Luo B,Kang N,Chen Y,et al.Oncogene miR-106a promotes proliferation and metastasis of prostate cancer cells by directly targeting PTEN in vivo and in vitro[J].Minerva Medica,2018,109(1):24. [5]Li N,Miao Y,Shan Y,et al.MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer[J].Cell Death and Disease,2017,8(5):e2796.[6]Liu X,Wang P,Zhang C,et al.Epidermal growth factor receptor (EGFR):A rising star in the era of precision medicine of lung cancer[J].Oncotarget,2017,8(30):50209-50220. [7]Du X,Shao Y,Qin HF,et al.ALK-rearrangement in non-small-cell lung cancer (NSCLC)[J].Thorac Cancer,2018,9(4):423-430. [8]Naderali E,Khaki AA,Rad JS,et al.Regulation and modulation of PTEN activity[J].Molecular Biology Reports,2018,45(6):2869-2881.[9]Han JG,Jiang YD,Zhang CH,et al.A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer[J].Ann Surg Treat Res,2017,92(2):55-66.[10]Feiersinger F,Nolte E,Wach S,et al.MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma[J].PLoS One,2016,11(2):e0148580.[11]Katar S,Baran O,Evran S,et al.Expression of miRNA-21,miRNA-107,miRNA-137 and miRNA-29b in meningioma[J].Clinical Neurology&Neurosurgery,2017(156):66-70.[12]Dai L,Chen F,Zheng Y,et al. miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling[J]. Front Biosci (Landmark Ed),2019(24):1426-1439.

相似文献/References:

[1]刘治利,葛明建.肺部磨玻璃结节的CT特征与治疗策略进展[J].医学信息,2018,31(11):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
　LIU Zhi-li,GE Ming-jian.Advances in CT Features and Treatment Strategies of Pulmonary Ground-glass Nodule[J].Medical Information,2018,31(09):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
[2]彭玉龙,张 露,陈荣辉,等.吉西他滨与培美曲塞联合卡铂治疗晚期肺腺癌的临床观察[J].医学信息,2018,31(11):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
　PENG Yu-long,ZHANG Lu,CHEN Rong-hui,et al.Clinical Observation of Gemcitabine and Pemetrexed Combined with Carboplatin in Treatment of Advanced Lung Adenocarcinoma[J].Medical Information,2018,31(09):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
[3]葛丽艳,王 琦,朱 宏,等.基于数据挖掘分析GPR35表达对肺腺癌预后的影响[J].医学信息,2018,31(23):86.[doi:10.3969/j.issn.1006-1959.2018.23.024]
　GE Li-yan,WANG Qi,ZHU Hong,et al.The Effect of GPR35 Expression on Prognosis of Lung Adenocarcinoma was Analyzed Based on Data Mining[J].Medical Information,2018,31(09):86.[doi:10.3969/j.issn.1006-1959.2018.23.024]
[4]刘贤丰,李子俊.恩度联合培美曲塞与顺铂治疗晚期肺腺癌的临床效果观察[J].医学信息,2019,32(03):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
　LIU Xian-feng,LI Zi-jun.Clinical Observation of Endo Combined with Pemetrexed and Cisplatin in the Treatment of Advanced Lung Adenocarcinoma[J].Medical Information,2019,32(09):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
[5]黄琪峰,郑琳琳,张 菁.生物信息学分析筛选肺腺癌靶基因及评估预后的价值[J].医学信息,2019,32(22):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
　HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value[J].Medical Information,2019,32(09):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
[6]唐怀慧,王忠帅,邵茜茜,等.基于TCGA数据库肺腺癌RNAs构建ceRNA网络的综合分析[J].医学信息,2020,33(07):90.[doi:10.3969/j.issn.1006-1959.2020.07.025]
　TANG Huai-hui,WANG Zhong-shuai,SHAO Qian-qian,et al.Comprehensive Analysis of Constructing ceRNA Network Based on TCGA Database of Lung Adenocarcinoma RNAs[J].Medical Information,2020,33(09):90.[doi:10.3969/j.issn.1006-1959.2020.07.025]
[7]张祥鑫,董星星,耿 涛,等.基于与铁死亡相关基因的肺腺癌的新型预后模型构建[J].医学信息,2021,34(15):96.[doi:10.3969/j.issn.1006-1959.2021.15.025]
　ZHANG Xiang-xin,DONG Xing-xing,GENG Tao,et al.Construction of A Novel Prognostic Model of Lung Adenocarcinoma Based on Genes Related to Iron Death[J].Medical Information,2021,34(09):96.[doi:10.3969/j.issn.1006-1959.2021.15.025]
[8]李 敖,王玉然,王文浩.基于公共数据库分析自噬相关基因在肺腺癌患者中的预后意义[J].医学信息,2022,35(22):17.[doi:10.3969/j.issn.1006-1959.2022.22.003]
　LI Ao,WANG Yu-ran,WANG Wen-hao.Prognostic Significance of Autophagy-related Genes in Patients with Lung Adenocarcinoma Based on Public Database Analysis[J].Medical Information,2022,35(09):17.[doi:10.3969/j.issn.1006-1959.2022.22.003]
[9]孔德伟,吴 铭,张 岩.肺腺癌骨转移肿瘤标记物的研究进展[J].医学信息,2022,35(23):171.[doi:10.3969/j.issn.1006-1959.2022.23.038]
　KONG De-wei,WU Ming,ZHANG Yan.Research Progress on Tumor Markers of Bone Metastasis in Lung Adenocarcinoma[J].Medical Information,2022,35(09):171.[doi:10.3969/j.issn.1006-1959.2022.23.038]
[10]思 璐,秦秋雯,沈 印,等.基于生物信息学分析筛选肺腺癌免疫预后相关lncRNA[J].医学信息,2023,36(01):1.[doi:10.3969/j.issn.1006-1959.2023.01.001]
　SI Lu,QIN Qiu-wen,SHEN Yin,et al.Screening of lncRNA Related to Immune Prognosis of Lung Adenocarcinoma Based on Bioinformatics Analysis[J].Medical Information,2023,36(09):1.[doi:10.3969/j.issn.1006-1959.2023.01.001]

更新日期/Last Update: 2020-05-01